Should You Buy Barinthus Biotherapeutics PLC (BRNS) Today? Analysis, Price Targets, and 2026 Outlook.
No data
No data
Growth
Profitability
Efficiency
Wall Street analysts forecast BRNS stock price to rise
1 Analyst Rating
Wall Street analysts forecast BRNS stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.670
Low
4
Averages
4
High
4
Current: 0.670
Low
4
Averages
4
High
4
H.C. Wainwright
H.C. Wainwright
Buy
maintain
$3 -> $4
AI Analysis
2025-11-17
Reason
H.C. Wainwright
H.C. Wainwright
Price Target
$3 -> $4
AI Analysis
2025-11-17
maintain
Buy
Reason
H.C. Wainwright raised the firm's price target on Barinthus Biotherapeutics to $4 from $3 and keeps a Buy rating on the shares following the Q3 report.
